Letter: The ethics of using inferior regimens in H. pylori randomised trials - Invited comment

Alimentary Pharmacology and Therapeutics

Volumn 35, Issue 7, 2012, Pages 854-856

  O'Connor, J P Anthony ^a   O'Morain, C A ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC RESISTANCE; CLINICAL RESEARCH; DRUG DOSE REGIMEN; GEOGRAPHIC DISTRIBUTION; HELICOBACTER INFECTION; HUMAN; INFECTION CONTROL; KOREA; LETTER; MEDICAL ETHICS; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; FEMALE; HELICOBACTER INFECTIONS; HUMANS; MALE; PROTON PUMP INHIBITORS;

EID: 84858218932     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2011.04951.x     Document Type: Letter

References (10)

1. Graham DY, Fischbach LA,. Letter: the ethics of using inferior regimens in H. pylori randomised trials. Aliment Pharmacol Ther 2012; 35: 852-4.
2. Kim YS, Kim SJ, Yoon JH, et al,. Randomised clinical trial: the efficacy of a 10-day sequential therapy vs. a 14-day standard proton pump inhibitor-based triple therapy for Helicobacter pylori in Korea. Aliment Pharmacol Ther 2011; 34: 1098-105.
3. Jafri NS, Hornung CA, Howden CW,. Meta-analysis: sequential therapy appears superior to standard therapy for Helicobacter pylori infection in patients naive to treatment. Ann Intern Med 2008; 148: 923-31. (Pubitemid 351860824)
4. Oh HS, Lee DH, Seo JY, et al,. Ten-day sequential therapy is more effective than proton-pump inhibitor-based therapy in Korea: a prospective randomized study. J Gastroenterol Hepatol 2011 [Epub ahead of print].
5. Malfertheiner P, Megraud F, O'Morain C, et al,. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 2007; 56: 772-81. (Pubitemid 46854190)
6. Graham DY, Lew GM, Malaty HM, et al,. Factors influencing the eradication of Helicobacter pylori with triple therapy. Gastroenterology 1992; 102: 493-6.
7. Qua CS, Manikam J, Goh KL,. Efficacy of 1-week proton pump inhibitor triple therapy as first-line Helicobacter pylori eradication regime in Asian patients: is it still effective 10 years on? J Dig Dis 2010; 11: 244-8.
8. Sasaki M, Ogasawara N, Utsumi K, et al,. Changes in 12-year first-line eradication rate of Helicobacter pylori based on triple therapy with proton pump inhibitor, amoxicillin and clarithromycin. J Clin Biochem Nutr 2010; 47: 53-8.
9. O'Morain CA, O'Connor JP,. Is sequential therapy superior to standard triple therapy for the treatment of Helicobacter pylori infection? Nat Clin Pract Gastroenterol Hepatol 2009; 6: 8-9.
10. Chey WD, Wong BC,. American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am J Gastroenterol 2007; 102: 1808-25. (Pubitemid 47206706)